Effect of topical propranolol gel on plasma renin, angiotensin ii and vascular endothelial growth factor in superficial infantile hemangiomas

Abstract

The effect of topical propranolol gel on the levels of plasma renin, angiotensin II (ATII) and vascular endothelial growth factor (VEGF) in superficial infantile hemangiomas (IHs) was investigated. Thirty-three consecutive children with superficial IHs were observed pre-treatment, 1 and 3 months after application of topical propranolol gel for the levels of plasma renin, ATII and VEGF in Department of General Surgery of Dongfang Hospital from February 2013 to February 2014. The plasma results of IHs were compared with those of 30 healthy infants of the same age from out-patient department. The clinical efficiency of topical propranolol gel at 1st, and 3rd month after application was 45%, and 82% respectively. The levels of plasma renin, ATII and VEGF in patients pre-treatment were higher than those in healthy infants (565.86±49.66 vs. 18.19±3.56, 3.20±0.39 vs 0.30±0.03, and 362.16±27.29 vs. 85.63±8.14, P<0.05). The concentrations of VEGF and renin at 1st and 3rd month after treatment were decreased obviously as compared with those pre-treatment (271.51±18.59 vs. 362.16±27.29, and 405.18±42.52 vs. 565.86±49.66 P<0.05; 240.80±19.89 vs. 362.16±27.29, and 325.90±35.78 vs. 565.86±49.66, P<0.05, respectively), but the levels of plasma ATII declined slightly (2.96±0.37 vs. 3.20±0.39, and 2.47±0.27 vs. 3.20±0.39, P>0.05). It was indicated that the increased renin, ATII and VEGF might play a role in the onset or development of IHs. Propranolol gel may suppress the proliferation of IHs by reducing VEGF.

Keywords

infantile hemangiomas / propranolol gel / angiotensin II / renin / vascular endothelial growth factor

References

[1] TanST, ItinteangT, LeadbitterP. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg, 2011, 64(3): 292-299 PMID: 20615772

[2] DosanjhA, ChangJ, BresnickS, et al. . In vitro characteristics of neonatal hemangioma endothelial cells: Similarities and differences between normal neonatal and fetal endothelial cells. J Cutan Pathol, 2000, 27(9): 441-450 PMID: 11028814

[3] NorthPE, WanerM, MizerackiA, et al. . GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Human Pathol, 2000, 31(1): 11-22

[4] Léauté-LabrèzeC, de la Dumas RoqueE, HubicheT, et al. . Propranolol for severe hemangiomas of infancy. N Engl J Med, 2008, 358(24): 2649-2651 PMID: 18550886

[5] LoizziM, De PalmaA, PagliaruloV, et al. . Propranolol as first-line treatment of a severe subglottic haemangioma. Eur J Cardiothorac Surg, 2013, 43(1): 187-189 PMID: 23045296

[6] LevittM, CoumouAD, GroeneveldL, et al. . Propranolol as first-line treatment in orbital infantile haemangiomas: a case series. Orbit, 2014, 33(3): 178-183 PMID: 24568543

[7] FuchsmannC, QuintalMC, GiguereC, et al. . Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg, 2011, 137(5): 471-478 PMID: 21576558

[8] WangL, XiaY, ZhaiYN, et al. . Topical propranolol hydrochloride gel for superficial infantile hemangiomas. J Huazhong Univ Sci Technol, 2012, 32(6): 923-926

[9] Broughton PipkinF, SmalesOR, O’CallaghanM. Renin and angiotensin levels in children. Arch Dis Child, 1981, 56(4): 298-302 PMCID: 1627246 PMID: 7018406

[10] YoumbissiTJ, TedongF, FairbankST, et al. . Plasma renin activity studies in a group of African neonates and children. J Trop Pediatr, 1990, 36(3): 128-130 PMID: 2194045

[11] StephensonTJ, PipkinFB, Elias-JonesAC. Factors influencing plasma renin and renin substrate in premature infants. Arch Dis Child, 1991, 66(10): 1150-1154 PMCID: 1590283 PMID: 1750766

[12] ItinteangT, BraschHD, TanST, et al. . Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg, 2011, 64(6): 759-765 PMID: 20870476

[13] ShiRZ, WangJC, HuangSH, et al. . Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells. Exp Cell Res, 2009, 315(1): 10-15 PMID: 18973754

[14] AchauerBM, ChangCJ, Vander KamVM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg, 1997, 99(5): 1301-1308 PMID: 9105356

[15] ChangLC, HaggstromAN, DroletBA, et al. . Growth characteristics of infantile hemangiomas: implications for management. Pediatrics, 2008, 122(2): 360-367 PMID: 18676554

[16] ZouHX, JiaJ, ZhangWF, et al. . Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma. Cardiovasc Pathol, 2013, 22(3): 203-210 PMID: 23151525

[17] KleinmanME, GreivesMR, ChurginSS, et al. . Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol, 2007, 27(12): 2664-2670 PMID: 17872454

[18] ComatiA, BeckH, HallidayW, et al. . Upregulation of hypoxia-inducible factor (HIF)-1α and HIF-2α in leptomeningeal vascular malformations of Sturge-Weber syndrome. J Neuropathol Exp Neurol, 2007, 66(1): 86-97 PMID: 17204940

[19] ChangEI, ChangEI, ThangarajahH, et al. . Hypoxia, hormones, an endothelial progenitor cells in hemangioma. Lymphat Res Biol, 2007, 5(4): 237-243 PMID: 18370914

[20] HuHT, MaQY, ZhangD, et al. . HIF-1alpha links beta- adrenoceptor agonists and pancreatic cancer cells under normoxic condition. Acta Pharmacol Sin, 2010, 31(1): 102-110 PMCID: 4002695 PMID: 20037603

[21] ParkSY, KangJH, JeongKJ, et al. . Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein dependent mechanism. Int J Cancer, 2011, 128(10): 2306-2316 PMID: 20715173

[22] ChimH, ArmijoBS, MillerE, et al. . Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A. Ann Surg, 2012, 256(1): 146-156 PMID: 22580939

[23] ForsytheJA, JiangBH, IyerNV, et al. . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol, 1996, 16(9): 4604-4613 PMCID: 231459 PMID: 8756616

[24] TangN, WangL, EskoJ, et al. . Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven autocrine loop necessary for tumorigenesis. Cancer Cell, 2004, 6(5): 485-495 PMID: 15542432